Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials
Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials
